Céline Ruegsegger

584 total citations
8 papers, 430 citations indexed

About

Céline Ruegsegger is a scholar working on Cellular and Molecular Neuroscience, Neurology and Molecular Biology. According to data from OpenAlex, Céline Ruegsegger has authored 8 papers receiving a total of 430 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Cellular and Molecular Neuroscience, 4 papers in Neurology and 2 papers in Molecular Biology. Recurrent topics in Céline Ruegsegger's work include Amyotrophic Lateral Sclerosis Research (4 papers), Genetic Neurodegenerative Diseases (3 papers) and Endoplasmic Reticulum Stress and Disease (2 papers). Céline Ruegsegger is often cited by papers focused on Amyotrophic Lateral Sclerosis Research (4 papers), Genetic Neurodegenerative Diseases (3 papers) and Endoplasmic Reticulum Stress and Disease (2 papers). Céline Ruegsegger collaborates with scholars based in Switzerland, Germany and Netherlands. Céline Ruegsegger's co-authors include Smita Saxena, J Pettavel, P Jaeger, Anand Goswami, Dirk Troost, Niran Maharjan, Joachim Weis, David Stucki, Benoît Zuber and Silvio Steiner and has published in prestigious journals such as The Lancet, Neuron and Nature Neuroscience.

In The Last Decade

Céline Ruegsegger

7 papers receiving 404 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Céline Ruegsegger Switzerland 7 173 136 114 108 71 8 430
Ivana Huvar United States 7 353 2.0× 109 0.8× 114 1.0× 51 0.5× 88 1.2× 8 611
Sami Khoshyomn United States 13 166 1.0× 137 1.0× 88 0.8× 31 0.3× 66 0.9× 31 496
Fabiana Lubieniecki Argentina 14 362 2.1× 100 0.7× 101 0.9× 126 1.2× 77 1.1× 53 651
Peter von Bossanyi Germany 11 328 1.9× 63 0.5× 103 0.9× 59 0.5× 98 1.4× 17 488
Seyedmehdi Shojaee United States 7 240 1.4× 169 1.2× 31 0.3× 68 0.6× 47 0.7× 13 508
Stephanie J. Byer United States 13 113 0.7× 206 1.5× 68 0.6× 52 0.5× 40 0.6× 17 405
Janet L. Oblinger United States 14 247 1.4× 155 1.1× 57 0.5× 42 0.4× 39 0.5× 21 456
Carole Auger France 15 205 1.2× 56 0.4× 45 0.4× 113 1.0× 100 1.4× 31 753
Minhui Xu China 13 150 0.9× 89 0.7× 61 0.5× 55 0.5× 13 0.2× 35 371
D Housman United States 11 438 2.5× 233 1.7× 90 0.8× 46 0.4× 52 0.7× 15 680

Countries citing papers authored by Céline Ruegsegger

Since Specialization
Citations

This map shows the geographic impact of Céline Ruegsegger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Céline Ruegsegger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Céline Ruegsegger more than expected).

Fields of papers citing papers by Céline Ruegsegger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Céline Ruegsegger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Céline Ruegsegger. The network helps show where Céline Ruegsegger may publish in the future.

Co-authorship network of co-authors of Céline Ruegsegger

This figure shows the co-authorship network connecting the top 25 collaborators of Céline Ruegsegger. A scholar is included among the top collaborators of Céline Ruegsegger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Céline Ruegsegger. Céline Ruegsegger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Moccia, Alden A., Christian Taverna, Sämi Schär, et al.. (2020). Prolonged rituximab maintenance in follicular lymphoma patients: long-term results of the SAKK 35/03 randomized trial. Blood Advances. 4(23). 5951–5957. 17 indexed citations
2.
Ruegsegger, Céline & Smita Saxena. (2016). Proteostasis impairment in ALS. Brain Research. 1648(Pt B). 571–579. 66 indexed citations
3.
Ruegsegger, Céline, David Stucki, Silvio Steiner, et al.. (2016). Impaired mTORC1-Dependent Expression of Homer-3 Influences SCA1 Pathophysiology. Neuron. 89(1). 129–146. 36 indexed citations
4.
Stucki, David, Céline Ruegsegger, Silvio Steiner, et al.. (2016). Mitochondrial impairments contribute to Spinocerebellar ataxia type 1 progression and can be ameliorated by the mitochondria-targeted antioxidant MitoQ. Free Radical Biology and Medicine. 97. 427–440. 50 indexed citations
5.
Maharjan, Niran, Céline Ruegsegger, Ruth Rehmann, et al.. (2015). Marinesco-Sjögren syndrome protein SIL1 regulates motor neuron subtype-selective ER stress in ALS. Nature Neuroscience. 18(2). 227–238. 80 indexed citations
6.
Ruegsegger, Céline, Niran Maharjan, Anand Goswami, et al.. (2015). Aberrant association of misfolded SOD1 with Na+/K+ATPase-α3 impairs its activity and contributes to motor neuron vulnerability in ALS. Acta Neuropathologica. 131(3). 427–451. 43 indexed citations
7.
Harder, F, et al.. (1984). Effect of transfusions of cadaver donors on survival of first kidney grafts in transfused recipients.. PubMed. 16(5). 1170–1.
8.
Jaeger, P, et al.. (1974). DETECTION OF RECURRENCE OF LARGE-BOWEL CARCINOMA BY RADIOIMMUNOASSAY OF CIRCULATING CARCINOEMBRYONIC ANTIGEN (C.E.A.). The Lancet. 304(7880). 535–540. 138 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026